Xeris Biopharma Holdings Inc (XERS)
3.065
+0.02
(+0.82%)
USD |
NASDAQ |
Nov 22, 14:05
Xeris Biopharma Holdings Revenue (Quarterly): 54.27M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 54.27M |
June 30, 2024 | 48.06M |
March 31, 2024 | 40.64M |
December 31, 2023 | 44.39M |
September 30, 2023 | 48.32M |
June 30, 2023 | 38.01M |
March 31, 2023 | 33.20M |
December 31, 2022 | 33.14M |
September 30, 2022 | 29.72M |
June 30, 2022 | 25.31M |
March 31, 2022 | 22.07M |
December 31, 2021 | 21.43M |
September 30, 2021 | 11.06M |
June 30, 2021 | 8.906M |
March 31, 2021 | 8.195M |
December 31, 2020 | 7.369M |
Date | Value |
---|---|
September 30, 2020 | 9.404M |
June 30, 2020 | 2.027M |
March 31, 2020 | 1.676M |
December 31, 2019 | 1.864M |
September 30, 2019 | 0.313M |
June 30, 2019 | 0.297M |
March 31, 2019 | 0.248M |
December 31, 2018 | 0.759M |
September 30, 2018 | 0.582M |
June 30, 2018 | 0.819M |
March 31, 2018 | 0.263M |
December 31, 2017 | 0.467M |
September 30, 2017 | 0.17M |
June 30, 2017 | 0.565M |
March 31, 2017 | 0.354M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.676M
Minimum
Mar 2020
54.27M
Maximum
Sep 2024
24.45M
Average
23.69M
Median
Revenue (Quarterly) Benchmarks
Zevra Therapeutics Inc | 3.695M |
NovaBay Pharmaceuticals Inc | 2.441M |
Palatin Technologies Inc | -- |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -15.74M |
Total Expenses (Quarterly) | 67.16M |
EPS Diluted (Quarterly) | -0.11 |
Enterprise Value | 615.09M |
Gross Profit Margin (Quarterly) | 74.95% |
Profit Margin (Quarterly) | -29.00% |
Earnings Yield | -14.36% |
Normalized Earnings Yield | -15.65 |